NeOnc Technologies Holdings Inc. Company Profile
NASDAQ: NTHIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NeOnc Technologies at a glance
NeOnc Technologies Holdings Inc. (NASDAQ: NTHI) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Calabasas, CA. NeOnc Technologies is led by Mr. Amir Farrokh Heshmatpour and employs about 5 people. At a market capitalization of $80.1 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001979414, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does NeOnc Technologies do?
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Business description based on the company's public filings.
Company information
- Legal name
- NeOnc Technologies Holdings Inc.
- Ticker
- NASDAQ: NTHI
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Amir Farrokh Heshmatpour
- Employees
- 5
- Headquarters
- 23975 Park Sorrento, Calabasas, CA, United States
- Phone
- 310 663 7831
- Website
- neonc.com
- Market cap
- $80.08M
- SEC CIK
- 0001979414
- Latest annual report
- 10-K/A · May 5, 2026
Companies similar to NeOnc Technologies
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SDEVStablecoin Development Corporation | 1.54 | -22.61% | $79.70M | vs NTHI |
| ACRVAcrivon Therapeutics Inc. | 1.91 | +2.14% | $81.85M | vs NTHI |
| ZYBTZhengye Biotechnology Holding Limited Class A | 1.73 | +50.45% | $81.99M | vs NTHI |
| TELOTelomir Pharmaceuticals Inc. | 1.12 | -2.61% | $82.45M | vs NTHI |
| INCRIntercure Ltd. | 5.17 | +2.99% | $77.57M | vs NTHI |
| HRTXHeron Therapeutics Inc. | 0.4061 | +13.37% | $77.10M | vs NTHI |
| RFLRafael Holdings Inc. Class B | 1.60 | +8.11% | $83.20M | vs NTHI |
| OSTXOS Therapies Incorporated | 1.62 | 0.00% | $75.82M | vs NTHI |